Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagerols, Mireia, Richarte, Vanesa, Sánchez-Mora, Cristina, Rovira, Paula, Soler Artigas, María, Garcia-Martínez, Iris, Calvo-Sánchez, Eva, Corrales, Montse, da Silva, Bruna Santos, Mota, Nina Roth, Victor, Marcelo Moraes, Rohde, Luis Augusto, Grevet, Eugenio Horacio, Bau, Claiton Henrique Dotto, Cormand, Bru, Casas, Miguel, Ramos-Quiroga, Josep Antoni, Ribasés, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789875/
https://www.ncbi.nlm.nih.gov/pubmed/29382897
http://dx.doi.org/10.1038/s41598-018-20194-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789875/
https://www.ncbi.nlm.nih.gov/pubmed/29382897
http://dx.doi.org/10.1038/s41598-018-20194-7

Ejemplares similares